326 related articles for article (PubMed ID: 18337563)
21. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
Morais C; Gobe G; Johnson DW; Healy H
Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
[TBL] [Abstract][Full Text] [Related]
22. Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway.
Zhang R; Xu Y; Ekman N; Wu Z; Wu J; Alitalo K; Min W
J Biol Chem; 2003 Dec; 278(51):51267-76. PubMed ID: 14532277
[TBL] [Abstract][Full Text] [Related]
23. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis.
Yoshida S; Ono M; Shono T; Izumi H; Ishibashi T; Suzuki H; Kuwano M
Mol Cell Biol; 1997 Jul; 17(7):4015-23. PubMed ID: 9199336
[TBL] [Abstract][Full Text] [Related]
24. FGD5 Regulates VEGF Receptor-2 Coupling to PI3 Kinase and Receptor Recycling.
Farhan MA; Azad AK; Touret N; Murray AG
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2301-2310. PubMed ID: 29051140
[TBL] [Abstract][Full Text] [Related]
25. The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathway.
Watari K; Nakamura M; Fukunaga Y; Furuno A; Shibata T; Kawahara A; Hosoi F; Kuwano T; Kuwano M; Ono M
Int J Cancer; 2012 Jul; 131(2):310-21. PubMed ID: 21826646
[TBL] [Abstract][Full Text] [Related]
26. BAZF, a novel component of cullin3-based E3 ligase complex, mediates VEGFR and Notch cross-signaling in angiogenesis.
Ohnuki H; Inoue H; Takemori N; Nakayama H; Sakaue T; Fukuda S; Miwa D; Nishiwaki E; Hatano M; Tokuhisa T; Endo Y; Nose M; Higashiyama S
Blood; 2012 Mar; 119(11):2688-98. PubMed ID: 22279058
[TBL] [Abstract][Full Text] [Related]
27. Prenatal inflammation impairs intestinal microvascular development through a TNF-dependent mechanism and predisposes newborn mice to necrotizing enterocolitis.
Yan X; Managlia E; Tan XD; De Plaen IG
Am J Physiol Gastrointest Liver Physiol; 2019 Jul; 317(1):G57-G66. PubMed ID: 31125264
[TBL] [Abstract][Full Text] [Related]
28. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
[TBL] [Abstract][Full Text] [Related]
29. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
30. Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells.
Albig AR; Becenti DJ; Roy TG; Schiemann WP
Microvasc Res; 2008 May; 76(1):7-14. PubMed ID: 18417156
[TBL] [Abstract][Full Text] [Related]
31. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
[TBL] [Abstract][Full Text] [Related]
32. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma.
Salvucci O; Basik M; Yao L; Bianchi R; Tosato G
J Leukoc Biol; 2004 Jul; 76(1):217-26. PubMed ID: 15075355
[TBL] [Abstract][Full Text] [Related]
34. Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6).
Smadja DM; Bièche I; Helley D; Laurendeau I; Simonin G; Muller L; Aiach M; Gaussem P
J Cell Mol Med; 2007; 11(5):1149-61. PubMed ID: 17979890
[TBL] [Abstract][Full Text] [Related]
35. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
Zhu GS; Tang LY; Lv DL; Jiang M
Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.
Hsieh MJ; Liu HT; Wang CN; Huang HY; Lin Y; Ko YS; Wang JS; Chang VH; Pang JS
J Mol Med (Berl); 2017 Mar; 95(3):323-333. PubMed ID: 27847966
[TBL] [Abstract][Full Text] [Related]
37. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
38. Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2.
Guidolin D; Albertin G; Spinazzi R; Sorato E; Mascarin A; Cavallo D; Antonello M; Ribatti D
Peptides; 2008 Nov; 29(11):2013-23. PubMed ID: 18692535
[TBL] [Abstract][Full Text] [Related]
39. Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells.
Altorjay I; Veréb Z; Serfozo Z; Bacskai I; Bátori R; Erdodi F; Udvardy M; Sipka S; Lányi Á; Rajnavölgyi É; Palatka K
Int J Immunopathol Pharmacol; 2011; 24(2):323-35. PubMed ID: 21658307
[TBL] [Abstract][Full Text] [Related]
40. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
